BlackRock Portfolio holdings
AUM
$5.23T
1-Year Return
24.48%
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
This Quarter Return
-3.54%
1 Year Return
+24.48%
3 Year Return
+103%
5 Year Return
+187.44%
10 Year Return
+430.33%
AUM
$2.93T
AUM Growth
-$181B
(-5.8%)
Cap. Flow
-$23.8B
Cap. Flow
% of AUM
-0.81%
Top 10 Holdings %
Top 10 Hldgs %
19.42%
Holding
5,969
New
125
Increased
2,136
Reduced
2,859
Closed
169
Top Buys
| 1 |
Tesla
TSLA
|
+$1.53B |
| 2 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$778M |
| 3 |
CoStar Group
CSGP
|
+$590M |
| 4 |
Healthcare Realty
HR
|
+$587M |
| 5 |
Rivian
RIVN
|
+$473M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.17B |
| 2 |
CDK
CDK Global, Inc.
CDK
|
+$1.02B |
| 3 |
ACC
American Campus Communities, Inc.
ACC
|
+$1.01B |
| 4 |
Chevron
CVX
|
+$980M |
| 5 |
Johnson & Johnson
JNJ
|
+$900M |
Sector Composition
| 1 | Technology | 22.17% |
| 2 | Healthcare | 15.33% |
| 3 | Financials | 12.53% |
| 4 | Consumer Discretionary | 10.4% |
| 5 | Industrials | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3901
Genasys
GNSS
$99.3M
| $1.93M | ﹤0.01% |
697,922
-3,141
| -0.4% | -$8.7K |
|
3902
Dimensional US Core Equity 2 ETF
DFAC
$37.7B
| $1.91M | ﹤0.01% |
85,865
-391
| -0.5% | -$8.7K |
|
3903
Mistras Group
MG
$299M
| $1.91M | ﹤0.01% |
427,927
+10,592
| +3% | +$47.2K |
|
|
VOXX
3904
DELISTED
VOXX International Corporation Class A
VOXX
| $1.9M | ﹤0.01% |
250,339
-21,946
| -8% | -$167K |
|
3905
First Savings Financial Group
FSFG
$189M
| $1.89M | ﹤0.01% |
82,272
+41,765
| +103% | +$960K |
|
3906
Lunai Bioworks Inc. Common Stock
RENB
$45.9M
| $1.89M | ﹤0.01% |
1,042,411
-14,065
| -1% | -$25.5K |
|
3907
Synchronoss Technologies
SNCR
$66.9M
| $1.89M | ﹤0.01% |
183,642
-1,332
| -0.7% | -$13.7K |
|
|
SOL
3908
Emeren Group
SOL
$96.5M
| $1.89M | ﹤0.01% |
374,007
+3,764
| +1% | +$19K |
|
|
LUNA
3909
DELISTED
Luna Innovations Incorporated
LUNA
| $1.88M | ﹤0.01% |
423,371
-53,911
| -11% | -$239K |
|
3910
Actinium Pharmaceuticals
ATNM
$50.8M
| $1.87M | ﹤0.01% |
252,854
+21,038
| +9% | +$155K |
|
3911
MarketWise
MKTW
$49.2M
| $1.86M | ﹤0.01% |
40,804
+3,087
| +8% | +$141K |
|
3912
Assembly Biosciences
ASMB
$168M
| $1.86M | ﹤0.01% |
94,490
-1,894
| -2% | -$37.3K |
|
|
TCRR
3913
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $1.85M | ﹤0.01% |
1,025,712
-11,982
| -1% | -$21.6K |
|
|
DBVT
3914
DBV Technologies
DBVT
$270M
| $1.85M | ﹤0.01% |
104,253
-2,593
| -2% | -$45.9K |
|
|
CNTB
3915
Connect Biopharma Holdings Limited Ordinary Shares
CNTB
$86.9M
| $1.84M | ﹤0.01% |
1,426,428
-8,532
| -0.6% | -$11K |
|
3916
FirstService
FSV
$9.31B
| $1.84M | ﹤0.01% |
15,427
-48
| -0.3% | -$5.71K |
|
3917
Comp X International
CIX
$285M
| $1.83M | ﹤0.01% |
112,773
-1,833
| -2% | -$29.8K |
|
3918
Vanguard Large-Cap ETF
VV
$45.3B
| $1.83M | ﹤0.01% |
11,186
-3,087
| -22% | -$505K |
|
|
SEEL
3919
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $1.83M | ﹤0.01% |
463
| – | – |
|
3920
Stereotaxis
STXS
$260M
| $1.82M | ﹤0.01% |
1,010,179
-12,233
| -1% | -$22K |
|
3921
Ardelyx
ARDX
$1.59B
| $1.82M | ﹤0.01% |
1,526,201
+230,527
| +18% | +$274K |
|
3922
OP Bancorp
OPBK
$215M
| $1.81M | ﹤0.01% |
162,787
+1,015
| +0.6% | +$11.3K |
|
3923
JPMorgan BetaBuilders Canada ETF
BBCA
$8.83B
| $1.81M | ﹤0.01% |
33,766
+7,916
| +31% | +$423K |
|
3924
SWK Holdings
SWKH
$176M
| $1.8M | ﹤0.01% |
133,627
+7,385
| +6% | +$99.5K |
|
3925
Carisma Therapeutics
CARM
$15.6M
| $1.79M | ﹤0.01% |
210,770
+6,337
| +3% | +$53.9K |
|